Variant report
Variant | nsv524806 |
---|---|
Chromosome Location | chr2:53013320-53052480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:53037286..53038157-chr2:53203093..53203814,3 | MCF-7 | breast: | |
2 | chr2:53048584..53050700-chr2:53053856..53055982,2 | K562 | blood: | |
3 | chr2:53037360..53037874-chr2:53428995..53429598,2 | MCF-7 | breast: | |
4 | chr2:53048846..53049807-chr2:53183875..53184416,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139135328 | chr2:53021825-53021826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189781796 | chr2:53021829-53021830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543480240 | chr2:53021837-53021838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75051235 | chr2:53021846-53021847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572615265 | chr2:53021909-53021910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551145063 | chr2:53021921-53021922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571431333 | chr2:53021925-53021926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546380684 | chr2:53021943-53021944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559993597 | chr2:53021965-53021966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533707766 | chr2:53021992-53021993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371168552 | chr2:53022057-53022058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73931478 | chr2:53022059-53022060 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs115015794 | chr2:53022070-53022071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34183638 | chr2:53022100-53022101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529667782 | chr2:53022109-53022110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114938566 | chr2:53022149-53022150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569896214 | chr2:53022150-53022151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374998319 | chr2:53022158-53022159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182284617 | chr2:53022161-53022162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11125445 | chr2:53022163-53022164 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs565535428 | chr2:53022164-53022165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187696586 | chr2:53022193-53022194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370720341 | chr2:53024202-53024203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113085471 | chr2:53024226-53024227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs785294 | chr2:53024241-53024242 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs367867831 | chr2:53024264-53024265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560356251 | chr2:53024272-53024273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529397160 | chr2:53024301-53024302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185372360 | chr2:53024317-53024318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562897423 | chr2:53024344-53024345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs137915156 | chr2:53024347-53024348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10209194 | chr2:53024383-53024384 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs571632877 | chr2:53024415-53024416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116528917 | chr2:53024443-53024444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547603712 | chr2:53024478-53024479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566407183 | chr2:53024527-53024528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563779566 | chr2:53024528-53024529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532697151 | chr2:53024540-53024541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535542044 | chr2:53024545-53024546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546207073 | chr2:53024572-53024573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555219453 | chr2:53024576-53024577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559742862 | chr2:53024581-53024582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568826477 | chr2:53024595-53024596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142461203 | chr2:53024645-53024646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528497611 | chr2:53024668-53024669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9309233 | chr2:53024686-53024687 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs578015292 | chr2:53024689-53024690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540388236 | chr2:53024703-53024704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553934788 | chr2:53024741-53024742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368385681 | chr2:53024808-53024809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53021800-53022200 | Enhancers | Adipose Nuclei | Adipose |
2 | chr2:53024200-53025200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:53025200-53029200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:53027800-53049000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr2:53029200-53029400 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
6 | chr2:53029200-53029800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr2:53029800-53033200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr2:53031200-53031800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr2:53031400-53031800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr2:53033200-53034400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr2:53037600-53037800 | Weak transcription | Left Ventricle | heart |
12 | chr2:53037800-53038000 | Enhancers | Left Ventricle | heart |
13 | chr2:53037800-53038200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr2:53037800-53038200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr2:53037800-53038200 | Enhancers | Pancreas | Pancrea |
16 | chr2:53038200-53044600 | Weak transcription | Pancreas | Pancrea |
17 | chr2:53046400-53046800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr2:53046800-53050600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr2:53050600-53051400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
20 | chr2:53051400-53058200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |